SAN DIEGO, CALIFORNIA - iCFO Capital Global, Inc., recently partnered with Small Eyes to raise $2M from iCFO Capital Global investor network nationwide.
Small Eyes is in the business of online myopia management for kids. Myopia is nearsightedness, which about 50 percent of school-age kids have now - it's a growing epidemic. Their initial product is a monthly bottle of low-dose atropine combined with on-demand customer care 24/7. This will give children the best chance to have the least myopia possible. Their doctors already have more than 500 young patients on atropine. They are raising money to do this at scale across the country as a telemedicine company similar to HIMS.com.
Highlights of the company:
• A real solution to the problem
• Doctors have no incentive or capability to do this
• Incredibly experienced team
• $75 per month for 10-20 years, plus upsell = $15k per customer
• No one quits atropine
• First-mover advantage in an exploding new market
• Cash cow: no need for later dilutive investment rounds
• Unicorn potential, plan to take company public
David Siegel has started more than a dozen companies, has written five books on technology and business, and has given more than 200 professional speeches around the world. He was once a candidate to be the dean of Stanford Business School. He recently wrote a book on marketing funnels. David’s two boys are on atropine for myopia management.
For more information about the company, please contact: david@dsiegel.com
iCFO Capital Global, Inc. provides a platform for Entrepreneurs to connect with our Private Investors that makes direct debt and equity investment for early-stage and expand growth businesses. To learn more about how your business can secure the funding it needs, visit: https://www.icfocapital.com/
